Study design and quality of reporting of randomized controlled trials of chronic idiopathic or autoimmune urticaria: review.
<h4>Background</h4>The recommended first-line therapy of chronic urticaria is second-generation antihistamines, but the modalities of treatment remains unclear. Numerous recommendations with heterogeneous conclusions have been published. We wondered whether such heterogeneous conclusions...
Guardado en:
Autores principales: | Elodie Le Fourn, Bruno Giraudeau, Olivier Chosidow, Marie-Sylvie Doutre, Gérard Lorette |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ceb2e86d36954d6fa07d74cdb6c50945 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Influence of initial treatment modality on long-term control of chronic idiopathic urticaria.
por: Sujeong Kim, et al.
Publicado: (2013) -
Participant informed consent in cluster randomized trials: review.
por: Bruno Giraudeau, et al.
Publicado: (2012) -
STUDIES ON THE ROLE OF CYTOKINES POLYMORPHISM IN PATHOGENESIS OF CHRONIC URTICARIA
por: N. I. Baranova, et al.
Publicado: (2015) -
Skin Prick Test with Aeroallergens in Patients with Chronic Urticaria
por: J Ghaffari, et al.
Publicado: (2012) -
FEATURES OF IMMUNE RESPONSE AND BASOPHIL ACTIVATION IN CHILDREN WITH CHRONIC URTICARIA
por: N. A. Sinelnikova, et al.
Publicado: (2015)